Doctor profile · Federal record

Dr. Harchetan Sandhu, M.D.

Rheumatology Physician (CMS: Rheumatology) · Chico, CA

  • NPI 1740243328
  • MIPS 71.9 / 100 · 2023
  • 30 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1488 East Ave Ste 130
Chico, CA 959261795
(530) 342-1310
fax (530) 342-1327
Mailing address
1488 East Ave
Chico, CA 959261795

Credentials & registration

NPPES · NUCC
NPI registered
April 2006 — 20 yrs on file
Profile last updated
March 3, 2008
Year of graduation
1996 — 30 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
California #A76840
Medicaid
CA #00A768400

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1740243328. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
92,240
Distinct HCPCS
9
Medicare allowed
$800,678
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 74,800 19 $5
J1602 Injection, golimumab, 1 mg, for intravenous use 15,100 17 $13
99213 Established patient office or other outpatient visit, 20-29 minutes 1,291 601 $93
99214 Established patient office or other outpatient visit, 30-39 minutes 395 232 $132
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 329 19 $78
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 131 25 $69
99204 New patient office or other outpatient visit, 45-59 minutes 125 125 $170
96372 Injection of drug or substance under skin or into muscle 58 20 $15
99205 New patient office or other outpatient visit, 60-74 minutes 11 11 $226

In context: peer comparison

Among 2 peers in this city , average services per provider: 7,699. This provider delivers 12× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,668
Transactions
77
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
UCB, Inc. 12 $282.17
Janssen Biotech, Inc. 11 $198.52
Amgen Inc. 13 $187.50
Lilly USA, LLC 9 $172.74
Boehringer Ingelheim Pharmaceuticals, Inc. 6 $147.09
GlaxoSmithKline, LLC. 6 $136.58
Novo Nordisk Inc 5 $100.37
PFIZER INC. 4 $84.39
Fresenius Kabi USA, LLC 2 $61.15
Novartis Pharmaceuticals Corporation 2 $51.96
Aurinia Pharma U.S., Inc. 2 $40.05
ABBVIE INC. 2 $37.17
Biocon Biologics Inc 1 $29.75
Organon Llc 1 $26.22
Kyowa Kirin, Inc. 1 $25.57

By nature of payment

Food and Beverage
$1,668

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,640
Patients
617
Total drug cost
$2,372,296
Drug Type Claims Patients Total cost
Methotrexate (Methotrexate Sodium) Brand 773 158 $27,506
Prednisone Generic 595 155 $6,285
Hydroxychloroquine Sulfate Generic 332 91 $20,972
Alendronate Sodium Generic 129 43 $2,153
Enbrel Sureclick (Etanercept) Brand 125 15 $943,414
Humira(Cf) Pen (Adalimumab) Brand 109 15 $942,871
Sulfasalazine Generic 98 24 $2,301
Allopurinol Generic 87 20 $1,267
Meloxicam Generic 86 29 $658
Leflunomide Generic 74 21 $7,294

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Harchetan Sandhu's medical specialty?
Dr. Harchetan Sandhu practices Rheumatology Physician in Chico, CA.
Where does Dr. Harchetan Sandhu practice?
Dr. Harchetan Sandhu practices at 1488 East Ave Ste 130, Chico, CA 959261795. Office phone: 5303421310.
What is Dr. Harchetan Sandhu's NPI?
Dr. Harchetan Sandhu's National Provider Identifier (NPI) is 1740243328, issued by NPPES.
Does Dr. Harchetan Sandhu accept Medicare assignment?
Dr. Harchetan Sandhu does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Harchetan Sandhu commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.